Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600
1. Guidewire will join S&P MidCap 400 on January 27, 2025. 2. Arrowhead Pharmaceuticals replaces Barnes Group in the S&P SmallCap 600. 3. Increased index inclusion may enhance GWRE's market visibility and investor interest. 4. Index changes often lead to price volatility for included stocks. 5. Apollo Global Management is acquiring Barnes Group, impacting market dynamics.